Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02644967
Brief Title: A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma (ILLUMINATE-204)

First Submitted : December 23, 2015
First Submitted that Met QC Criteria : December 31, 2015
First Posted : January 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 23, 2019
Last Update Posted : April 25, 2019